-
1
-
-
58149156441
-
Vitamin D levels and patient outcome in chronic kidney disease
-
Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C: Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009; 75: 88-95.
-
(2009)
Kidney Int
, vol.75
, pp. 88-95
-
-
Ravani, P.1
Malberti, F.2
Tripepi, G.3
Pecchini, P.4
Cutrupi, S.5
Pizzini, P.6
Mallamaci, F.7
Zoccali, C.8
-
2
-
-
70350077680
-
Chronic kidney disease, hypovitaminosis D, and mortality in the United States
-
Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, Martins D, Adler SG, Norris KC: Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 2009; 76: 977-983.
-
(2009)
Kidney Int
, vol.76
, pp. 977-983
-
-
Mehrotra, R.1
Kermah, D.A.2
Salusky, I.B.3
Wolf, M.S.4
Thadhani, R.I.5
Chiu, Y.W.6
Martins, D.7
Adler, S.G.8
Norris, K.C.9
-
3
-
-
49449105803
-
Vitamin D status of chronic kidney disease patients living in a sunny country
-
Cuppari L, Carvalho AB, Draibe SA: Vitamin D status of chronic kidney disease patients living in a sunny country. J Ren Nutr 2008; 18: 408-414.
-
(2008)
J Ren Nutr
, vol.18
, pp. 408-414
-
-
Cuppari, L.1
Carvalho, A.B.2
Draibe, S.A.3
-
4
-
-
49249095954
-
Hypovitaminosis D in chronic kidney disease
-
Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, Takasu J, Adler S, Norris K: Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1144-1151.
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 1144-1151
-
-
Mehrotra, R.1
Kermah, D.2
Budoff, M.3
Salusky, I.B.4
Mao, S.S.5
Gao, Y.L.6
Takasu, J.7
Adler, S.8
Norris, K.9
-
5
-
-
10644280669
-
Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study
-
Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ: Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004; 24: 503-510.
-
(2004)
Am J Nephrol
, vol.24
, pp. 503-510
-
-
Gonzalez, E.A.1
Sachdeva, A.2
Oliver, D.A.3
Martin, K.J.4
-
6
-
-
34250779828
-
Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis
-
Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR: Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int 2007; 11: 315-321.
-
(2007)
Hemodial Int
, vol.11
, pp. 315-321
-
-
Del Valle, E.1
Negri, A.L.2
Aguirre, C.3
Fradinger, E.4
Zanchetta, J.R.5
-
7
-
-
23744437488
-
Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients
-
Shah N, Bernardini J, Piraino B: Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients. Perit Dial Int 2005; 25: 362-366.
-
(2005)
Perit Dial Int
, vol.25
, pp. 362-366
-
-
Shah, N.1
Bernardini, J.2
Piraino, B.3
-
8
-
-
84855186451
-
Risk factors for hypovitaminosis D in nondialyzed chronic kidney disease patients
-
Figuiredo-Dias V CL, Garcia-Lopes MG, Carvalho AB, Draibe SA, Kamimura MA: Risk factors for hypovitaminosis D in nondialyzed chronic kidney disease patients. J Ren Nutr 2012; 22: 4-11.
-
(2012)
J Ren Nutr
, vol.22
, pp. 4-11
-
-
Figuiredo-Dias, V.C.L.1
Garcia-Lopes, M.G.2
Carvalho, A.B.3
Draibe, S.A.4
Kamimura, M.A.5
-
9
-
-
83055172414
-
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
-
K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 2003; 42:S1-S201.
-
(2003)
Am J Kidney Dis
, vol.42
-
-
-
10
-
-
68949114585
-
Prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)
-
KDIGO Clinical Practice Guideline For The Diagnosis Evaluation
-
KDIGO Clinical Practice Guideline For The Diagnosis, Evaluation, Prevention, And Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; 76:S1-S130.
-
(2009)
Kidney Int Suppl
, vol.76
-
-
-
11
-
-
34250771472
-
Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD
-
Al-Aly Z, Qazi RA, Gonzalez EA, Zeringue A, Martin KJ: Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 2007; 50: 59-68.
-
(2007)
Am J Kidney Dis
, vol.50
, pp. 59-68
-
-
Al-Aly, Z.1
Qazi, R.A.2
Gonzalez, E.A.3
Zeringue, A.4
Martin, K.J.5
-
12
-
-
33847669753
-
Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease
-
Zisman AL, Hristova M, Ho LT, Sprague SM: Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 2007; 27: 36-43.
-
(2007)
Am J Nephrol
, vol.27
, pp. 36-43
-
-
Zisman, A.L.1
Hristova, M.2
Ho, L.T.3
Sprague, S.M.4
-
13
-
-
40649108122
-
Cholecalciferol (vitamin D 3 ) therapy and vitamin D insufficiency in patients with chronic kidney disease: A randomized controlled pilot study
-
Chandra P, Binongo JN, Ziegler TR, Schlanger LE, Wang W, Someren JT, Tangpricha V: Cholecalciferol (vitamin D 3 ) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract 2008; 14: 10-17.
-
(2008)
Endocr Pract
, vol.14
, pp. 10-17
-
-
Chandra, P.1
Binongo, J.N.2
Ziegler, T.R.3
Schlanger, L.E.4
Wang, W.5
Someren, J.T.6
Tangpricha, V.7
-
14
-
-
66349087471
-
Vitamin D insufficiency and treatment with oral vitamin D 3 in northern-dwelling patients with chronic kidney disease
-
Rucker D, Tonelli M, Coles MG, Yoo S, Young K, McMahon AW: Vitamin D insufficiency and treatment with oral vitamin D 3 in northern-dwelling patients with chronic kidney disease. J Nephrol 2009; 22: 75-82.
-
(2009)
J Nephrol
, vol.22
, pp. 75-82
-
-
Rucker, D.1
Tonelli, M.2
Coles, M.G.3
Yoo, S.4
Young, K.5
McMahon, A.W.6
-
15
-
-
77950793603
-
Treatment of vitamin D deficiency in CKD patients with ergocalciferol: Are current K/DOQI treatment guidelines adequate?
-
Qunibi WY, Abdellatif A, Sankar S, Hamdan Z, Lin FY, Ingle J, Cadena A, Gelfond J, Kasinath B: Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate? Clin Nephrol 2010; 73: 276-285.
-
(2010)
Clin Nephrol
, vol.73
, pp. 276-285
-
-
Qunibi, W.Y.1
Abdellatif, A.2
Sankar, S.3
Hamdan, Z.4
Lin, F.Y.5
Ingle, J.6
Cadena, A.7
Gelfond, J.8
Kasinath, B.9
-
16
-
-
9044235771
-
Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes
-
Canada-USA (CANUSA) Peritoneal Dialysis Study Group
-
Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996; 7: 198-207.
-
(1996)
J Am Soc Nephrol
, vol.7
, pp. 198-207
-
-
-
17
-
-
35448966232
-
Low 25-hydroxyvitamin D concentrations in obese women: Their clinical significance and relationship with anthropometric and body composition variables
-
Vilarrasa N, Maravall J, Estepa A, Sanchez R, Masdevall C, Navarro MA, Alia P, Soler J, Gomez JM: Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 2007; 30: 653-658.
-
(2007)
J Endocrinol Invest
, vol.30
, pp. 653-658
-
-
Vilarrasa, N.1
Maravall, J.2
Estepa, A.3
Sanchez, R.4
Masdevall, C.5
Navarro, M.A.6
Alia, P.7
Soler, J.8
Gomez, J.M.9
-
18
-
-
0033847865
-
Decreased bioavailability of vitamin D in obesity
-
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF: Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.
-
(2000)
Am J Clin Nutr
, vol.72
, pp. 690-693
-
-
Wortsman, J.1
Matsuoka, L.Y.2
Chen, T.C.3
Lu, Z.4
Holick, M.F.5
-
19
-
-
71149116580
-
Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index
-
Lee P, Greenfield JR, Seibel MJ, Eisman JA, Center JR: Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med 2009; 122: 1056-1060.
-
(2009)
Am J Med
, vol.122
, pp. 1056-1060
-
-
Lee, P.1
Greenfield, J.R.2
Seibel, M.J.3
Eisman, J.A.4
Center, J.R.5
-
20
-
-
49649116629
-
Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults
-
Blum M, Dallal GE, Dawson-Hughes B: Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults. J Am Coll Nutr 2008; 27: 274-279.
-
(2008)
J Am Coll Nutr
, vol.27
, pp. 274-279
-
-
Blum, M.1
Dallal, G.E.2
Dawson-Hughes, B.3
-
21
-
-
77957800242
-
A 16-week randomized clinical trial of 2000 international units daily vitamin D 3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness
-
Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y, Li K, Bassali R, Guo DH, Thomas J, Pierce GL, White J, Holick MF, Zhu H: A 16-week randomized clinical trial of 2000 international units daily vitamin D 3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 2010; 95: 4584-4591.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 4584-4591
-
-
Dong, Y.1
Stallmann-Jorgensen, I.S.2
Pollock, N.K.3
Harris, R.A.4
Keeton, D.5
Huang, Y.6
Li, K.7
Bassali, R.8
Guo, D.H.9
Thomas, J.10
Pierce, G.L.11
White, J.12
Holick, M.F.13
Zhu, H.14
-
22
-
-
40649094686
-
Predominant role of 25OHD in the negative regulation of PTH expression: Clinical relevance for hypovitaminosis D
-
Kawahara M, Iwasaki Y, Sakaguchi K, Taguchi T, Nishiyama M, Nigawara T, Tsugita M, Kambayashi M, Suda T, Hashimoto K: Predominant role of 25OHD in the negative regulation of PTH expression: clinical relevance for hypovitaminosis D. Life Sci 2008; 82: 677-683.
-
(2008)
Life Sci
, vol.82
, pp. 677-683
-
-
Kawahara, M.1
Iwasaki, Y.2
Sakaguchi, K.3
Taguchi, T.4
Nishiyama, M.5
Nigawara, T.6
Tsugita, M.7
Kambayashi, M.8
Suda, T.9
Hashimoto, K.10
-
23
-
-
33747075392
-
25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells
-
Ritter CS, Armbrecht HJ, Slatopolsky E, Brown AJ: 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int 2006; 70: 654-659.
-
(2006)
Kidney Int
, vol.70
, pp. 654-659
-
-
Ritter, C.S.1
Armbrecht, H.J.2
Slatopolsky, E.3
Brown, A.J.4
-
24
-
-
35848947037
-
Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells
-
Krajisnik T, Bjorklund P, Marsell R, Ljunggren O, Akerstrom G, Jonsson KB, Westin G, Larsson TE: Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007; 195: 125-131.
-
(2007)
J Endocrinol
, vol.195
, pp. 125-131
-
-
Krajisnik, T.1
Bjorklund, P.2
Marsell, R.3
Ljunggren, O.4
Akerstrom, G.5
Jonsson, K.B.6
Westin, G.7
Larsson, T.E.8
-
25
-
-
33845663542
-
Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells
-
Van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, Uitterlinden AG, Pols HA, van Leeuwen JP: Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. FASEB J 2006; 20: 2417-2419.
-
(2006)
FASEB J
, vol.20
, pp. 2417-2419
-
-
Van Driel, M.1
Koedam, M.2
Buurman, C.J.3
Hewison, M.4
Chiba, H.5
Uitterlinden, A.G.6
Pols, H.A.7
Van Leeuwen, J.P.8
-
26
-
-
34548497123
-
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study
-
Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, Kuen E, Konig P, Kraatz G, Mann JF, Muller GA, Kohler H, Riegler P: Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 2007; 18: 2600-2608.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 2600-2608
-
-
Fliser, D.1
Kollerits, B.2
Neyer, U.3
Ankerst, D.P.4
Lhotta, K.5
Lingenhel, A.6
Ritz, E.7
Kronenberg, F.8
Kuen, E.9
Konig, P.10
Kraatz, G.11
Mann, J.F.12
Muller, G.A.13
Kohler, H.14
Riegler, P.15
-
27
-
-
79951889923
-
FGF-23 as a predictor of renal outcome in diabetic nephropathy
-
Titan SM, Zatz R, Graciolli FG, Dos Reis LM, Barros RT, Jorgetti V, Moyses RM: FGF-23 as a predictor of renal outcome in diabetic nephropathy. Clin J Am Soc Nephrol 2011; 6: 241-247.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 241-247
-
-
Titan, S.M.1
Zatz, R.2
Graciolli, F.G.3
Dos Reis, L.M.4
Barros, R.T.5
Jorgetti, V.6
Moyses, R.M.7
-
28
-
-
77956159370
-
FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment
-
Seiler S, Reichart B, Roth D, Seibert E, Fliser D, Heine GH: FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment. Nephrol Dial Transplant 2010; 25: 3983-3989.
-
(2010)
Nephrol Dial Transplant
, vol.25
, pp. 3983-3989
-
-
Seiler, S.1
Reichart, B.2
Roth, D.3
Seibert, E.4
Fliser, D.5
Heine, G.H.6
-
29
-
-
49249104701
-
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
-
Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592.
-
(2008)
N Engl J Med
, vol.359
, pp. 584-592
-
-
Gutierrez, O.M.1
Mannstadt, M.2
Isakova, T.3
Rauh-Hain, J.A.4
Tamez, H.5
Shah, A.6
Smith, K.7
Lee, H.8
Thadhani, R.9
Juppner, H.10
Wolf, M.11
|